Nearly 5,000 Robotic Surgeries and counting.
More than any other hospital in the world.
Robotic prostate surgery started here - pioneered by Mani Menon, M.D., and the Vattikuti Urology Institute.
No surgical team in the world has more experience performing robotic prostatectomy, a procedure that not only removes the cancer but also has a high probability of preserving sexual function and urinary control. We also were one of the first facilities in the world to use robotic surgery for removing kidney cancer and bladder cancer with reconstruction.
Patients from all 50 states and more than two dozen countries have traveled to the Vattikuti Urology Institute. Learn more about Robotic Surgery.
Leaders in Urology
The Vattikuti Urology Institute is a comprehensive clinical, research and teaching institute that consistently ranks among the best in the nation. Here you will find some of the world's first and most progressive approaches to treating prostate cancer and other urological conditions.
The Vattikuti Urology Institute:
-
Was named a "Best Hospital" for Urology by U.S. News and World Report for 2009.
-
Uses the daVinci Surgical system.
-
Has dedicated more than $20 million to basic and clinical urology research.
-
Hosts the International Robotic Urology Symposium, which attracts physicians from around the world interested in learning robotic surgery from Dr. Menon and his team.
-
Is committed to training the next generation of highly skilled robotic surgeons. Our physicians and fellows helped establish urologic robotic surgery programs at New York-Presbyterian/Weill Cornell, New York-Presbyterian Hospital/Columbia University Medical Center, and Hospital of the University of Pennsylvania, among others.
-
Maintains a database - considered to be the most comprehensive of its kind in the world - of more than 6,000 patients with prostate cancer to determine the most effective therapies.
- Is the only center in the world offering suicide gene therapy - developed in the Henry Ford Department of Radiation Oncology and currently in Phase III clinical trial - as a way to eliminate prostate cancer cells without damaging surrounding normal tissue.
With top clinicians and researchers, the Vattikuti Urology Institute offers a comprehensive, multidisciplinary approach, backed by evidence-based medicine, to ensure the best outcome for each patient.
Visit: http://www.henryford.com